Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
249 hedge funds and large institutions have $3.58B invested in Abiomed Inc in 2015 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 104 increasing their positions, 75 reducing their positions, and 33 closing their positions.
39% more repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 75
21% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 33
2% more funds holding
Funds holding: 243 → 249 (+6)
8% more call options, than puts
Call options by funds: $8.21M | Put options by funds: $7.62M
3% less capital invested
Capital invested by funds: $3.68B → $3.58B (-$94.3M)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$55.1M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$24.4M |
| 3 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$22.5M |
| 4 |
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
|
+$18.6M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$104M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$25.3M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$22.3M |
| 4 |
Renaissance Technologies
New York
|
-$21.2M |
| 5 |
Two Sigma Investments
New York
|
-$20.9M |
ABMD Hedge Fund Activity: Q4 2015 in Review
249 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2015, worth a combined $3.58B — down 2.6% from $3.68B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new ABMD positions and 33 closed out — a net gain of 7 holders — while 104 added to existing stakes and 75 trimmed.
The largest buyer was Eagle Asset Management, opening a new position worth an estimated $55.1M. The largest seller was 1832 Asset Management, exiting entirely with an estimated $104M sold.
- 249 institutional investors held Abiomed Inc (ABMD) as of Q4 2015, up from 243 in Q3 2015.
- Funds reported $3.58B of Abiomed Inc stock for Q4 2015, down 2.6% quarter-over-quarter.
- 40 funds opened new Abiomed Inc positions in Q4 2015 and 33 closed out, a net change of +7 holders.
- The largest Abiomed Inc buyer in Q4 2015 was Eagle Asset Management, an estimated $55.1M added.
- The largest Abiomed Inc seller in Q4 2015 was 1832 Asset Management, an estimated $104M sold.
Based on aggregated 13F filings for Q4 2015.